Christopher A. Kuebler, Director at NEKTAR THERAPEUTICS (NKTR), sold 30,000 shares at $58.66 ($1.8M) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Open-market sale of $1.8M NKTR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| WAT | SELL | 2023-08-07 | $1.2M | — | Filing → |
| WAT | SELL | 2022-05-23 | $1.3M | — | Filing → |
| WAT | SELL | 2021-08-19 | $1.2M | — | Filing → |